Next 10 |
2025-07-10 07:54:49 ET More on Jazz Pharmaceuticals Jazz Pharmaceuticals: I See Big Potential In This Stock As An Investor Jazz Pharmaceuticals: One Step Forward, One Back Jazz Pharmaceuticals gets EU nod for Ziihera Read the full article on Seeking Alpha ...
Jazz Pharmaceuticals Names Renee Gala as President and Chief Executive Officer PR Newswire – Selection Follows Robust Succession Process Led by the Board – – Bruce Cozadd to Retire as CEO and Remain Chairperson of the Board of Directors ȁ...
2025-07-07 09:30:00 ET Jazz Pharmaceuticals plc's (NASDAQ: JAZZ ) stock price has continued to fluctuate between $97 and $120 over the past three months, even as it has made significant progress in developing its oncology franchise.... Read the full article on Seeking Alph...
2025-07-01 09:52:26 ET More on Jazz Pharmaceuticals Jazz Pharmaceuticals: One Step Forward, One Back Jazz Pharmaceuticals plc (JAZZ) Q1 2025 Earnings Call Transcript Jazz Pharma gets FDA priority review for lung cancer therapy Zepzelca Jazz Pharmaceuticals su...
Jazz Pharmaceuticals Receives European Commission Marketing Authorization for Ziihera® (zanidatamab) for the Treatment of Advanced HER2-Positive Biliary Tract Cancer PR Newswire – Conditional approval based on positive results from the HERIZON-BTC-01 Phase 2b t...
2025-06-15 23:27:38 ET Headquartered in Bedford, MA, Stoke Therapeutics ( STOK ) was founded in 2014 with a focus on developing RNA-based medicines to treat severe diseases by increasing protein expression.... Read the full article on Seeking Alpha For further details see: ...
2025-06-14 10:30:00 ET Despite the war between Israel and Iran that began on June 13 , Amgen's ( AMGN ) stock price continues to hold above its VWAP [volume-weighted average price] and has gained about 15% in the last month.... Read the full article on Seeking ...
2025-06-10 08:36:39 ET More on Jazz Pharmaceuticals Jazz Pharmaceuticals: One Step Forward, One Back Jazz Pharmaceuticals plc (JAZZ) Q1 2025 Earnings Call Transcript Jazz Pharmaceuticals succeeds in late-stage study of lung cancer treatment SA Asks: What are ...
Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination Granted U.S. FDA Priority Review for First-Line Maintenance Treatment of Extensive-Stage Small Cell Lung Cancer PR Newswire Target Action (PDUFA) Date set for October 7, 2025 Application ...
Jazz Pharmaceuticals Presents Late-Breaking Phase 4 Data Showcasing Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Outcomes in Narcolepsy at SLEEP 2025 PR Newswire First presentation of the Phase 4 XYLO switch study reports blood press...
News, Short Squeeze, Breakout and More Instantly...
Jazz Pharmaceuticals plc Company Name:
JAZZ Stock Symbol:
NASDAQ Market:
0.98% G/L:
$112.48 Last:
768,861 Volume:
$110.51 Open:
$112.48 Close:
Jazz Pharmaceuticals plc Website:
Jazz Pharmaceuticals Names Renee Gala as President and Chief Executive Officer PR Newswire – Selection Follows Robust Succession Process Led by the Board – – Bruce Cozadd to Retire as CEO and Remain Chairperson of the Board of Directors ȁ...
Jazz Pharmaceuticals Receives European Commission Marketing Authorization for Ziihera® (zanidatamab) for the Treatment of Advanced HER2-Positive Biliary Tract Cancer PR Newswire – Conditional approval based on positive results from the HERIZON-BTC-01 Phase 2b t...
Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination Granted U.S. FDA Priority Review for First-Line Maintenance Treatment of Extensive-Stage Small Cell Lung Cancer PR Newswire Target Action (PDUFA) Date set for October 7, 2025 Application ...